Albiglutide is a glucagon-like peptide-1 agonist (GLP-1) biologic drug indicated in the treatment of type 2 diabetes. It is a dipeptidyl peptidase-4-resistant glucagon-like peptide-1 dimer fused to human albumin.
CAT# | 10-101-158 |
CAS | 782500-75-8 |
Synonyms/Alias | Naliglutide; Albugon;GSK 716155; Naliglutide; Syncria;Eperzan;Tanzeum;UNII-5E7U48495E |
M.F/Formula | C3232H5032N864O979S41 |
M.W/Mr. | 72970.4029 |
Application | Albiglutide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. |
Areas of Interest | Type 2 diabetes mellitus |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
PT-141, also called as Bremelanotide, is a derivative for Melanotan 2 (M2). Unlike M2, PT-141 lacks C-terminal a ...
Fertirelin acetate, classified into peptide hormone, is a gonadotropin-releasing hormone (GnRH) antagonist or ...
GR 94800, is a linear heptapeptide with the structure of PhCO-Ala-Ala-D-Trp-Phe-D-Pro-Nle Amide, which is a high ...
Introduce of lipopeptide Lipopeptide (peptidolipid), also known as acylpeptide, is composed of hydrophilic peptide bond and l ...
The mammalian precursor gene proglucagon, which contains the glucagon sequence together with two structurally related glucago ...